• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道细菌提供遗传和分子报告系统以识别特定疾病。

Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases.

作者信息

Dicks Leon M T

机构信息

Department of Microbiology, Stellenbosch University, Stellenbosch 7600, South Africa.

出版信息

Int J Mol Sci. 2024 Apr 17;25(8):4431. doi: 10.3390/ijms25084431.

DOI:10.3390/ijms25084431
PMID:38674014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11050607/
Abstract

With genetic information gained from next-generation sequencing (NGS) and genome-wide association studies (GWAS), it is now possible to select for genes that encode reporter molecules that may be used to detect abnormalities such as alcohol-related liver disease (ARLD), cancer, cognitive impairment, multiple sclerosis (MS), diabesity, and ischemic stroke (IS). This, however, requires a thorough understanding of the gut-brain axis (GBA), the effect diets have on the selection of gut microbiota, conditions that influence the expression of microbial genes, and human physiology. Bacterial metabolites such as short-chain fatty acids (SCFAs) play a major role in gut homeostasis, maintain intestinal epithelial cells (IECs), and regulate the immune system, neurological, and endocrine functions. Changes in butyrate levels may serve as an early warning of colon cancer. Other cancer-reporting molecules are colibactin, a genotoxin produced by polyketide synthetase-positive strains, and spermine oxidase (SMO). Increased butyrate levels are also associated with inflammation and impaired cognition. Dysbiosis may lead to increased production of oxidized low-density lipoproteins (OX-LDLs), known to restrict blood vessels and cause hypertension. Sudden changes in SCFA levels may also serve as a warning of IS. Early signs of ARLD may be detected by an increase in regenerating islet-derived 3 gamma (REG3G), which is associated with changes in the secretion of mucin-2 (Muc2). Pro-inflammatory molecules such as cytokines, interferons, and TNF may serve as early reporters of MS. Other examples of microbial enzymes and metabolites that may be used as reporters in the early detection of life-threatening diseases are reviewed.

摘要

借助从下一代测序(NGS)和全基因组关联研究(GWAS)中获得的遗传信息,现在有可能筛选出编码报告分子的基因,这些报告分子可用于检测诸如酒精性肝病(ARLD)、癌症、认知障碍、多发性硬化症(MS)、糖尿病肥胖症和缺血性中风(IS)等异常情况。然而,这需要全面了解肠-脑轴(GBA)、饮食对肠道微生物群选择的影响、影响微生物基因表达的条件以及人体生理学。细菌代谢产物如短链脂肪酸(SCFAs)在肠道稳态中起主要作用,维持肠道上皮细胞(IECs),并调节免疫系统、神经和内分泌功能。丁酸盐水平的变化可能是结肠癌的早期预警信号。其他癌症报告分子包括多酮合成酶阳性菌株产生的基因毒素大肠杆菌素和精胺氧化酶(SMO)。丁酸盐水平升高还与炎症和认知障碍有关。肠道微生物群失调可能导致氧化型低密度脂蛋白(OX-LDLs)生成增加,已知OX-LDLs会使血管收缩并导致高血压。SCFA水平的突然变化也可能是IS的预警信号。ARLD的早期迹象可能通过再生胰岛衍生3γ(REG3G)的增加来检测,REG3G与粘蛋白-2(Muc2)分泌的变化有关。细胞因子、干扰素和肿瘤坏死因子等促炎分子可能是MS的早期报告分子。本文综述了其他可在危及生命疾病早期检测中用作报告分子的微生物酶和代谢产物的实例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/8684d493f26c/ijms-25-04431-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/9ecdf6be34b6/ijms-25-04431-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/5d0065ad3370/ijms-25-04431-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/6a6ea059a957/ijms-25-04431-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/9ef311376b22/ijms-25-04431-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/700b0baee177/ijms-25-04431-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/77ae1ec6c319/ijms-25-04431-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/4b2de919ae45/ijms-25-04431-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/8684d493f26c/ijms-25-04431-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/9ecdf6be34b6/ijms-25-04431-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/5d0065ad3370/ijms-25-04431-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/6a6ea059a957/ijms-25-04431-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/9ef311376b22/ijms-25-04431-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/700b0baee177/ijms-25-04431-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/77ae1ec6c319/ijms-25-04431-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/4b2de919ae45/ijms-25-04431-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a621/11050607/8684d493f26c/ijms-25-04431-g008.jpg

相似文献

1
Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases.肠道细菌提供遗传和分子报告系统以识别特定疾病。
Int J Mol Sci. 2024 Apr 17;25(8):4431. doi: 10.3390/ijms25084431.
2
Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS.胃肠道、微生物群与多发性硬化症(MS)以及肠道微生物群与中枢神经系统之间的联系。
Curr Microbiol. 2022 Dec 17;80(1):38. doi: 10.1007/s00284-022-03150-7.
3
The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?多发性硬化症中的肠脑轴。其功能障碍是疾病的病理性触发因素还是后果?
Front Immunol. 2021 Sep 21;12:718220. doi: 10.3389/fimmu.2021.718220. eCollection 2021.
4
Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases.细菌代谢产物:肠道微生物群与皮肤疾病之间的联系。
Int J Mol Sci. 2023 Feb 9;24(4):3494. doi: 10.3390/ijms24043494.
5
Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.短链脂肪酸:缓解应激诱导的脑肠轴改变的微生物代谢产物。
J Physiol. 2018 Oct;596(20):4923-4944. doi: 10.1113/JP276431. Epub 2018 Aug 28.
6
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.短链脂肪酸:肠道-脑轴信号的微生物代谢产物。
Mol Cell Endocrinol. 2022 Apr 15;546:111572. doi: 10.1016/j.mce.2022.111572. Epub 2022 Jan 20.
7
Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis.丁酸盐通过抑制小胶质细胞介导的神经炎症和调节微生物-肠道-脑轴来改善慢性酒精性中枢神经损伤。
Biomed Pharmacother. 2023 Apr;160:114308. doi: 10.1016/j.biopha.2023.114308. Epub 2023 Jan 28.
8
Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis.人脐带间充质干细胞通过调节肠道微生物群-SCFAs-免疫轴改善结肠炎症。
Stem Cell Res Ther. 2023 Sep 25;14(1):271. doi: 10.1186/s13287-023-03471-9.
9
Perturbation of the lipid metabolism and intestinal inflammation in growing pigs with low birth weight is associated with the alterations of gut microbiota.低出生体重生长猪的脂代谢紊乱和肠道炎症与肠道微生物群的改变有关。
Sci Total Environ. 2020 Jun 1;719:137382. doi: 10.1016/j.scitotenv.2020.137382. Epub 2020 Feb 20.
10
Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome.创伤性脑损伤后持续的肠道菌群失调和粪便短链脂肪酸减少及其对神经预后的影响。
J Neurotrauma. 2021 Sep 15;38(18):2610-2621. doi: 10.1089/neu.2020.7506. Epub 2021 Jun 7.

引用本文的文献

1
Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut-Liver Axis in Tumorigenesis and Therapy.肝癌中的基因组改变与微生物群串扰:肿瘤发生与治疗中的肠-肝轴
Genes (Basel). 2025 Jul 30;16(8):920. doi: 10.3390/genes16080920.
2
Gut Microbiota in Heart Failure-The Role of Inflammation.心力衰竭中的肠道微生物群——炎症的作用。
Biomedicines. 2025 Apr 9;13(4):911. doi: 10.3390/biomedicines13040911.
3
Internet-Based Abnormal Chromosomal Diagnosis During Pregnancy Using a Noninvasive Innovative Approach to Detecting Chromosomal Abnormalities in the Fetus: Scoping Review.

本文引用的文献

1
Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases.治疗胃肠道感染性疾病的肠道微生物组学靶向方法。
Int J Mol Sci. 2023 Oct 27;24(21):15654. doi: 10.3390/ijms242115654.
2
Alcohol drinking alters oral microbiota to modulate the progression of alcohol-related liver disease.饮酒会改变口腔微生物群,从而调节酒精性肝病的进展。
iScience. 2023 Sep 19;26(10):107977. doi: 10.1016/j.isci.2023.107977. eCollection 2023 Oct 20.
3
Microbiota in Irritable Bowel Syndrome and Endometriosis: Birds of a Feather Flock Together-A Review.
基于互联网的孕期染色体异常诊断:使用无创创新方法检测胎儿染色体异常的范围综述
JMIR Bioinform Biotechnol. 2024 Oct 16;5:e58439. doi: 10.2196/58439.
肠易激综合征和子宫内膜异位症中的微生物群:物以类聚——综述
Microorganisms. 2023 Aug 15;11(8):2089. doi: 10.3390/microorganisms11082089.
4
Gastroparesis: The Complex Interplay with Microbiota and the Role of Exogenous Infections in the Pathogenesis of the Disease.胃轻瘫:与微生物群的复杂相互作用以及外源感染在疾病发病机制中的作用
Microorganisms. 2023 Apr 25;11(5):1122. doi: 10.3390/microorganisms11051122.
5
Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance.靶向 PD-L2-RGMb 克服了与微生物组相关的免疫治疗耐药性。
Nature. 2023 May;617(7960):377-385. doi: 10.1038/s41586-023-06026-3. Epub 2023 May 3.
6
Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points.利福昔明治疗腹泻型肠易激综合征的单个及多个症状:使用新终点的分析。
Clin Ther. 2023 Mar;45(3):198-209. doi: 10.1016/j.clinthera.2023.01.010. Epub 2023 Mar 14.
7
Gut Microbial Metabolites on Host Immune Responses in Health and Disease.健康与疾病状态下肠道微生物代谢产物对宿主免疫反应的影响
Immune Netw. 2023 Feb 24;23(1):e6. doi: 10.4110/in.2023.23.e6. eCollection 2023 Feb.
8
NOX Dependent ROS Generation and Cell Metabolism.NOX 依赖性 ROS 生成与细胞代谢。
Int J Mol Sci. 2023 Jan 20;24(3):2086. doi: 10.3390/ijms24032086.
9
The human microbial exposome: expanding the Exposome-Explorer database with gut microbial metabolites.人类微生物暴露组:用肠道微生物代谢物扩展暴露组探索者数据库。
Sci Rep. 2023 Feb 2;13(1):1946. doi: 10.1038/s41598-022-26366-w.
10
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy.肿瘤内微生物群:在癌症发生、发展和治疗效果中的作用。
Signal Transduct Target Ther. 2023 Jan 16;8(1):35. doi: 10.1038/s41392-022-01304-4.